Company Immunotech Biopharm Ltd

Equities

6978

KYG4721A1004

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Hong Kong S.E. Other stock markets 04:09:13 2024-04-23 am EDT			5-day change	1st Jan Change
3.14 ^HKD	-6.82%		-9.51%	-37.20%

Mar. 29	Immunotech Biopharm Posts Nearly 335 Million Yuan Loss in 2023	MT
Mar. 28	Immunotech Biopharm Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR-T cell series products. EAL is a multi-target cellular immunotherapy product. It also provides cell cryopreservation services. The Company mainly conducts its businesses in the domestic market.

Number of employees: 211

Managers	Title	Age	Since
Yu Wang CEO	Chief Executive Officer	57	19-08-22
Ning Yang DFI	Director of Finance/CFO	43	19-03-31
Yu Zhang CTO	Chief Tech/Sci/R&D Officer	60	18-12-23
Jian Zhang SAM	Sales & Marketing	53	18-02-04

Members of the board	Title	Age	Since
Rui Hua Wang BRD	Director/Board Member	60	23-03-23
Ying Dian Wang BRD	Director/Board Member	63	18-12-31
Ran Tao BRD	Director/Board Member	59	21-08-22
Chi Kit Ng BRD	Director/Board Member	51	20-05-31
Zheng Tan CHM	Chairman	46	18-03-31
Yu Wang CEO	Chief Executive Officer	57	19-08-22
Su Jiu Peng BRD	Director/Board Member	44	18-12-31
Fan Yang BRD	Director/Board Member	43	23-03-23
Dong Hu Wang BRD	Director/Board Member	69	23-08-24

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	514,584,000	228,862,314 ( 44.48 %)	0	44.48 %

Name	Equities	%	Valuation
Zheng Tan 36.04 %	185,480,000	36.04 %	88 M $
TASLY PHARMACEUTICAL GROUP CO., LTD 18.87 %	97,102,571	18.87 %	46 M $
Hyun Chul Jung 8.710 %	44,820,000	8.710 %	21 M $
Bosera Asset Management Co., Ltd. 0.1947 %	1,002,000	0.1947 %	477 543 $
China Asset Management (Hong Kong) Ltd. 0.001360 %	7,000	0.001360 %	3 336 $

Immunotech Biopharm Ltd.

Guosheng Technology Park No.1 Kangding Street

, Beijing

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
IMMUNOTECH BIOPHARM LTD	-35.00%	221M
REGENERON PHARMACEUTICALS, INC.	+2.49%	96.73B
ARGENX SE	-0.23%	21.31B
BIONTECH SE	-16.61%	21.21B
GENMAB A/S	-4.97%	18.79B
WUXI APPTEC CO., LTD.	-42.14%	16.37B
BEIGENE, LTD.	-27.40%	13.68B
NEUROCRINE BIOSCIENCES, INC.	+1.44%	13.44B
SAREPTA THERAPEUTICS, INC.	+21.29%	10.98B
LEGEND BIOTECH CORPORATION	-21.79%	8.56B

Bio Therapeutic Drugs